Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Apelins are substances which occur naturally in the body, and have an important role in heart disease. They have been shown to make blood vessels dilate, and improve the way the heart works.
The investigators have devised 2 sets of experiments to investigate how the apelins affect blood vessels.
In the first group of experiments,the investigators will give healthy volunteers up to 3 different apelin substances, and use special research techniques to see how they affect the way that blood vessels work in the forearm.
In the second group of experiments, the apelins will be given along with another form of apelin which blocks the effects of apelin in laboratory experiments. The investigators want to see if it blocks the effects of apelin in healthy humans.
The investigators intend to test the hypothesis that:
Apelin agonists are vasodilators in human resistance vessels, this effect will be blocked by an apelin receptor antagonist.
This study will help us to understand more about how apelins work, and to suggest how they might be used to treat heart disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Apelin agonist infusion | Experimental | Studies to measure change in blood flow in response to apelin agonists (1/10/100nmol) using forearm venous occlusion plethysmography and Aellig hand vein technique. |
|
| Apelin receptor antagonist infusion | Experimental | Aellig hand vein technique will be used to investigate the change in vein diameter in response to an apelin blocking agent |
|
| Apelin agonist/antagonist co-infusion | Experimental | Forearm blood flow study to measure blood flow by forearm venous occlusion plethysmography following intraarterial infusion of apelin receptor agonists and antagonist. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Forearm venous occlusion plethysmography | Procedure | Forearm venous occlusion plethysmography to study to measure forearm blood flow during intra-arterial infusion of the apelin peptides. |
| Measure | Description | Time Frame |
|---|---|---|
| Forearm blood flow measured by forearm plethysmography in response to infused vasodilators | 2-3 hours | |
| Change in hand vein diameter measured by Aellig hand vein technique, in response to study peptides | 2-3 hours |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ian B Wilkinson, FRCP DM | University of Cambridge | Study Director |
| Anthony P Davenport, MA PhD | University of Cambridge | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vascular Research Unit | Cambridge | CB2 0QQ | United Kingdom |
Not provided
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Aellig hand vein technique | Procedure | Hand vein measurements will be used to assess the response to apelin peptides and apelin receptor blocker in the human hand vein vascular bed. |
|
| Apelin agonist infusion | Other | Escalating doses of apelin (1/10/100nmol/min) will be administered. |
|
| Apelin receptor antagonist infusion | Other | Dose finding study (range 1-300nmol/min) and co-infusion study with apelin peptides |
|